Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia.

Chelsey LeitingEllen KernsJoshua C EuteneuerRussell J McCullohEric S Peeples

Published in: American journal of perinatology (2022)

· The risks and benefits of IC use in infants with BPD are incompletely understood.. · IC use is common in infants with BPD (25%) and severe BPD (43%) varies widely by hospital (0-66% of patients with BPD received an IC).. · Hospital experience did not account for the wide interhospital variation in IC use..

Keyphrases

healthcare
acute care
adverse drug
cystic fibrosis
emergency department
risk assessment